Bahram Valamehr, President and CEO at FATE THERAPEUTICS INC (FATE), sold 8,705 shares at $1.54 ($13K) on 2025-01-10, disclosed to the SEC on 2025-01-13.
Seasonal sale ($13k) by President and CEO — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2024-01-10 | $49K | — | Filing → |